Polypeptides and coagulation therapy

Details Polypeptides and coagulation therapy Polypeptides and coagulation therapy

1994-11-14

2000-08-29

Wax, Robert A.

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

Hydrolase

C12N 974

Patent

active

061107212

ABSTRACT:
Novel polypeptides (NPs) are provided which are capable of protein C activation without significant fibrinogen clotting activity, and vice versa. NPs having enhanced protein C activating properties in relation to fibrinogen clotting are useful in particular as anticoagulants and in screening for substances that agonize or antagonize this property and in diagnostic procedures to determine the status of patients' activated protein C-mediated anticoagulant pathway. Procoagulant NPs are useful to promote clotting in the course of therapy of solid tumors, as an impregnate for bandages, or in diagnostic assays. The NPs are produced in recombinant cell culture or by in vitro methods.

REFERENCES:
patent: 4303592 (1981-12-01), Laura et al.
patent: 4775624 (1988-10-01), Bang et al.
patent: 4849403 (1989-07-01), Stocker et al.
patent: 4959314 (1990-09-01), Mark et al.
patent: 5093117 (1992-03-01), Lawrence et al.
patent: 5116943 (1992-05-01), Koths et al.
patent: 5147638 (1992-09-01), Esmon et al.
patent: 5223408 (1993-06-01), Goeddel et al.
patent: 5304482 (1994-04-01), Sambrook et al.
patent: 5338546 (1994-08-01), Bennett et al.
patent: 5352664 (1994-10-01), Carney et al.
Comp et al., "Activation of Protein C in Vivo," J Clin Invest 70:127-134 (1982).
Hyde et al., "Isolation and Characterization of an in vivo Thrombin-Induced Anticoagulant Activity," Scand. J. Haemat. 13:121-128 (1974).
Stryer, L. Biochemistry, Third Edition. New York: Freeman and Co. 1988, pp. 136-138.
Chang, J.-Y. (1991) "Deciphering the structural elements of hirudin C-terminal peptide that bind to the fibrinogen recognition site of alpha-thrombin" Biochem. 30:6656-6661.
Lundblad, R.L. et al. (Mar. 1988) "The reaction of bovine alpha-thrombin with tetranitromethane" J. Biol. Chem. 263(8):3729-3734.
MacGillivray, R.T.A. et al. (1986) "Recombinant genetic approaches to functional mapping of thrombin" Ann. New York Acad. Sci. 485:73-79.
Martin, P.D. et al. (1992) "The structure of residues 7-16 of the A-alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-angstroms resolution" J. Biol. Chem. 267(11):7911-7920, Apr. 1992.
Miyata, T. et al. (1992) "Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activity" Biochem. 31:7457-7462.
Sheehan et al, "Molecular Mapping of the Heparin Binding Exosite of Thrombin," Blood 82:206a, Abstract No. 809 (1993).
Ye et al, "Glycosaminoglycan contributions to both Protein C activation and thrombin inhibition involve a common arginini-rich site in thrombin," J Biol Chem 269(8):17965-17970 (1994).
Alberts, et al., "Most Mutations in Proteins Are Deleterious and Are Eliminated by Natural Selection," Molecular Biology of the Cell, pp. 215 (1983).
Baum, R., "Mutated Proteins Unlocking Secrets of How Native Proteins Function," Chemical & Engineering News 69:23-30 (1991).
Gibbs, et al., "Conversion of Thrombin into an Anticoagulant by Protein Engineering," Nature 378:413-416 (1995).
Ni, et al., "High-Resolution NMR Studies of Fibrinogen-like Peptides in Solution: Structural Basis for the Bleeding Disorder Caused by a Single Mutation of Gly(12) to Val(12) in the A.alpha. Chain of Human Fibrinogen Rouen," Biochemistry (2nd Ed.) 28:3106-3119 (1989).
Paborsky, et al., "The Single-Stranded DNA Aptamer-binding Site of Human Thrombin," Journal of Biological Chemistry 268(28):20808-20811 (1993).
Tsiang, et al., "Functional Mapping of the Surface Residues of Human Thrombin," Journal of Biological Chemistry 270(28):16854-16863 (1995).
Wells, et al., "In Vivo Formation and Stability of Engineered Disulfide Bonds in Subtilisin," Journal of Biological Chemistry 261(14):6564-6570 (1986).
Barnhart, Marion I., "Immunochemistry," W.H. Segers, Ed., "Blood Clotting Enzymology" (1967).
Degen et al., "Characterization of the Complementary Deoxyribonucleic Acid and Gene Coding for Human Prothrombin," Biochemistry 22:2087-2097 (1983).
Ehrlich et al., "Recombinant Human Protein C Derivatives: Altered Response to Calcium Resulting in Enhanced Activation by Thrombin," The EMBO Journal 9(8):2367-2373 (1990).
Esmon et al., "Inflammation and Coagulation: Linked Processes Potentially Regulated Through A Common Pathway Mediated by Protein C ," Thrombosis and Haemostasis 66(1):160-165 (1991).
Gan et al., "Characterization of the Heparin Binding Exosite of Thrombin," Thrombosis and Haemostasis: Poster Presentation No. 1783 69:1044 (Jul. 8, 1993).
Gomi et al., "Antithrombotic Effect of Recombinant Human Thrombomodulin on Thrombin-Induced Thromboembolism in Mice," Blood 75(7):1396-1398 (1990).
Hanson et al., "Antithrombotic Effects of Thrombin-Induced Activation of Endogenous Protein C in Primates," The American Society for Clinical Investigation, Inc. 92:2003-2012 (Oct. 1993).
Hedner et al., "Introduction to Hemostasis and the Vitamin K-Dependent Coagulation Factors," The Metabolic Basis Of Inherited Disease II 6 ed., Chapter 84, pp. 2107-2373 (1989).
Horrevoets et al., "Thrombin-Variable Region 1 (VR1)," The Journal of Biological Chemistry 268(2):779-782 (1993).
Hung et al., "Mirror Image Antagonists of Thrombin-Induced Platelet Activation Based on Thrombin Receptor Structure," J. Clin. Invest. 89:444-450 (1992).
Le Bonniec et al., "Glu-192-->Gln Substitution in Thrombin Mimics the Catalytic Switch Induced by Thrombomodulin," Proc. Natl. Acad. Sci. USA 88:7371-7375 (1991).
Le Bonniec et al., "Thrombin Glu-39 Restricts the P'3 Specificity to Nonacidic Residues," The Journal of Biological Chemistry 266(21): 13796-13803 (1991).
Li et al., "Mutagenesis On The Loop Thr147 To Ser158 of Human Thrombin Does Not Abolish Thrombomodulin Binding Site," Thrombosis and Haemostasis: Poster Presentation No. 1787 69:1045 (Jul. 8, 1993).
Magnusson et al., "Complete Primary Structure of Prothrombin: Isolation, Structure and Reactivity of Ten Carboxylated Glutamic Acid Residues and Regulation of Prothrombin Activation by Thrombin," Proteases and Biological Control 2:123-149 (1975).
Mann et al., "Biochemistry of Thrombin," Hemostasis and Thrombosis 2 ed., Chapter 10, pp. 148-161 (1987).
Mann et al., "The Molecular Weights of Bovine Thrombin and Its Primary Autolysis Products," Thrombin Peptides 244(23):6555-6557 (Dec. 10, 1969).
Naray-Szabo et al., "Rational Design In Genetic Engineering: Dream or Reality? A Priori Predictions For Thrombin and Ribonuclease A Mutants," Journal of Molecular Structure (Theochem) 200:401-412 (1989).
Neurath, Hans, "Evolution of Proteolytic Enzymes," Science 224:350-357 (Apr. 27, 1984).
Richardson et al., "Enhancing Protein C Interaction With Thrombin Results in a Clot-Activated Anticoagulant," Letters to Nature 360:261-264 (Nov. 19, 1992).
Rosenberg et al., "Multiple Bovine Thrombin Components," The Journal of Biological Chemistry 245(19):5049-5056 (1970).
Seegers et al., "Preparation and Properties of Thrombin," Archives of Biochemistry and Biophysics 128:194-201 (1968).
Sheehan et al., "Identification of the Heparin-Binding Exosite of Thrombin By Site-Directed Mutagenesis," Thrombosis and Haemostasis: Poster Presentation No. 1784 69:1044 (Jul. 8, 1993).
Sheehan et al., "Mutagenesis of Thrombin Selectively Modulates Inhibition by Serpins Heparin Cofactor II and Antithrombin III," The Journal of Biological Chemistry 268(5):3639-3645 (1993).
Suzuki et al., "A Thrombin-Based Peptide Corresponding to the Sequence of the Thrombomodulin-Binding Site Blocks the Procoagulant Activities of Thrombin," The Journal of Biological Chemistry 266(28):18498-18501 (1991).
White et al., "Structure-Function Relations in Platelet-Thrombin Reactions," The Journal of Biological Chemistry 256(4):1763-1766 (1981).
Banfield et al, "Partial characterization of vertebrate prothrombin cDNAs: Amplification and sequence analysis of the B chain of thrombin from nine different species," Proc Natl Acad Sci 89:2779-2783 (1992).
Bar-Shavit et al, "An Arg-Gly-Asp Sequence Within Thrombin Promotes Endothelial Cell Adhesion," J Cell Biol 112(2):335-344 (1991).
Bar-Shavit et al, "Identification of a thrombin sequence with growth factor activity on macrophages," Proc Nat

Affiliated with

Also associated with

Rating

Polypeptides and coagulation therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polypeptides and coagulation therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptides and coagulation therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1248768